Why Are Visual Assistive Mobile Applications Underused by Low Vision Patients?
Alexis G Malkin, Nicole C Ross, Melissa W Chun...
https://pubmed.ncbi.nlm.nih.gov/35213868/Actively Recruiting
Led by University of California, Los Angeles · Updated on 2026-09-24
350
Participants Needed
9
Research Sites
N/A
Total Duration
Researchers are evaluating telerehabilitation compared to in-office care for follow-up training in adults with low vision who have received new magnification or visual assistive devices. The study aims to improve quality of life by helping participants use these devices for daily activities like reading. It also explores whether environmental data from Bluetooth low energy beacon sensors can monitor if patients stop using their magnification devices, potentially enhancing patient care. Participants will be randomly assigned to receive low vision rehabilitation either through videoconferencing telerehabilitation or in-person visits at a clinic. The rehabilitation involves evaluation and training for using hand-held optical magnifiers, portable electronic video magnifiers, high near add powers, visual assistive mobile apps, stand magnifiers, or CCTVs. The study follows participants for up to 13 months, with assessments at multiple time points. During the study, participants will complete various vision and reading tests at baseline and at 1, 4, 8, 12, and 13 months after receiving their device. Researchers will also collect surveys on rehabilitation satisfaction and feedback from close acquaintances. The use of magnifiers will be monitored for frequency and duration. The primary outcome measures changes in activity inventory related to device use. The study involves randomization and single masking, with follow-up evaluations extending up to 13 months.
CONDITIONS
Beacon Sensors and Telerehabilitation to Assess and Improve Use of Devices (BeST-AID) for Low Vision
U
UCLA Study Coordinator
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Los Angeles
Lead Sponsor
University of Nebraska
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Telerehabilitation with Low Vision Provider | Usual Care In-Office |
|---|---|---|
| What it is | Remote evaluation and training for visually impaired adults, using video or phone to teach and support use of new magnification or visual assistive devices. | Evaluation and training provided in person at a clinic, with hands-on guidance for use of new magnification and assistive devices. |
| Role in the trial | Investigational arm testing whether remote telerehabilitation is as effective as in-person care for device use and visual function. | Active comparator; represents standard in-person low vision rehabilitation against which telerehabilitation is compared. |
| Primary use | Delivers instruction and support for learning to use new magnification devices at home through telehealth modalities. | Participants attend in-person sessions for device training and visual rehabilitation tailored to their needs. |
| How it is given or performed | Sessions are delivered remotely by a provider using video or telephone; strategies are individualized and may include tips for device setup, technique, and troubleshooting. | Participants travel to a clinic where they receive direct face-to-face evaluation and hands-on training with their magnification devices. |
| Evidence status | Systematic review data suggests telerehabilitation can improve reading ability and participant satisfaction in people with low vision; however, outcome evidence remains limited and some trials report no substantial difference from in-person care. | In-person low vision rehabilitation improves device use and reading, as supported by both clinical guidelines and controlled studies; considered established care though individual outcomes can vary. |
| Important limitations | Internet access, device familiarity, and communication barriers can affect telerehabilitation success. Not all participants may be comfortable with or able to receive remote guidance. | Requires physical travel to a clinic, which may be difficult for some patients and may limit access for those living far from a center or with mobility barriers. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening and enrollment visit
Duration - 13 months
Participants receive low vision rehabilitation training either remotely through videoconferencing or in an office setting to help use magnification and visual assistive devices.
Multiple visits and assessments over 13 months at baseline, 1, 4, 8, 12, and 13 months
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexis G Malkin, Nicole C Ross, Melissa W Chun...
https://pubmed.ncbi.nlm.nih.gov/35213868/John E Kaminski, Patrick D Yoshinaga, Melissa W Chun...
https://pubmed.ncbi.nlm.nih.gov/36951854/Ava K Bittner, Max Estabrook, Niki Dennis
https://pubmed.ncbi.nlm.nih.gov/34770374/Ava Katherine Bittner, John E Kaminski, Nicole C Ross...
https://pubmed.ncbi.nlm.nih.gov/36067410/Ava Katherine Bittner, Andrew J Jacobson, Rakin Khan
https://pubmed.ncbi.nlm.nih.gov/30169359/Ava K Bittner, Patrick D Yoshinaga, Thanitsara Rittiphairoj...
https://pubmed.ncbi.nlm.nih.gov/36637057/Ava K Bittner, Patrick D Yoshinaga, John D Shepherd...
https://pubmed.ncbi.nlm.nih.gov/35917136/Ava Katherine Bittner, Patrick Yoshinaga, Angie Bowers...
https://pubmed.ncbi.nlm.nih.gov/30169361/University of California, Los Angeles
Lead Sponsor
University of Nebraska
Collaborating Sponsor